Page 286 - Vitamin D and Cancer

11 Vitamin D and Hematologic Malignancies 273

71. Pan Q, Simpson RU (Mar 26, 1999) c-myc intron element-binding proteins are required for
1,25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the
involvement of HOXB4. J Biol Chem 274(13):8437–44
72. Rots NY, Liu M, Anderson EC, Freedman LP (Apr, 1998) A differential screen for ligand-
regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid
leukemic cells. Mol Cell Biol 18(4):1911–8
73. Du H, Daftary GS, Lalwani SI, Taylor HS (Sep, 2005) Direct regulation of HOXA 10 by
1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol
Endocrinol 19(9):2222–33
74. Koschmieder S, Agrawal S, Radomska HS, Huettner CS, Tenen DG, Ottmann OG, Berdel
WE, Serve HL, Müller-Tidow C (Feb, 2007) Decitabine and vitamin D3 differentially affect
hematopoietic transcription factors to induce monocytic differentiation. Int J Oncol
30(2):349–55
75. Kawagoe H, Potter M, Ellis J, Grosveld GC (Sep 1, 2004) TEL2, an ETS factor expressed
in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibi-
tory effect of TELl on ras-induced cellular transformation. Cancer Res 64(17):6091–100
76. Lasky SR, Iwata K, Rosmarin AG, Caprio DG, Maizel AL (Aug 25, 1995) Differential regu-
lation of JunD by dihydroxycholecalciferol in human chronic myelogenous leukemia cells.
J Biol Chem 270(34):19676–9
77. Gaynor R, Simon K, Koeffler P (June 15, 1991) Expression of c-jun during macrophage
differentiation of HL-60 cells. Blood 77(12):2618–23
78. Urahama N, Ito M, Sada A, Yakushijin K, Yamamoto K, Okamura A, Minagawa K, Hato A,
Chihara K, Roeder RG, Matsui T (Dec, 2005) The role of transcriptional coactivator
TRAP220 in myelomonocytic differentiation. Genes Cells 10(12):1127–37
79. Ito M, Yuan CX, Okano HJ, Darnell RB, Roeder RG (Apr, 2000) Involvement of the
TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development
and thyroid hormone action. Mol Cell 5(4):683–93
80. Ruthardt M, Testa U, Nervi C, Ferrucci PF, Grignani F, Puccetti E, Grignani F, Peschle C,
Pelicci PG (Aug, 1997) Opposite effects of the acute promyelocytic leukemia PML-retinoic
acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid sig-
nalling. Mol Cell Biol 17(8):4859–69
81. Puccetti E, Obradovic D, Beissert T, Bianchini A, Washburn B, Chiaradonna F, Boehrer S,
Hoelzer D, Ottmann OG, Pelicci PG, Nervi C, Ruthardt M (Dec 1, 2002) AML-associated
translocation products block vitamin D(3)-induced differentiation by sequestering the vita-
min D(3) receptor. Cancer Res 62(23):7050–8
82. Ward JO, McConnell MJ, Carlile GW, Pandolfi PP, Licht JD, Freedman LP (Dec 1, 2001)
The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger,
regulates 1,25-dihydroxyvitarnin D(3) induced monocytic differentiation of U937 cells
through a physical interaction with vitamin D(3) receptor. Blood 98(12):3290–300
83. Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z, Cayre YE (Dec 22, 1989) Down-
regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of
promyelocytic leukemia cells. Cell 59(6):959–68
84. Savli H, Aalto Y, Nagy B, Knuutila S, Pakkala S (Sep, 2002) Gene expression analysis of
1,25(OH)2D3 dependent differentiation of HL-60 cells: a cDNA array study. Br J Haematol
118(4):1065–70
85. Suzuki T, Tazoe H, Taguchi K, Koyama Y, Ichikawa H, Hayakawa S, Munakata H, Isemura
M (June 2006) DNA microarray analysis of changes in gene expression induced by
1,25-dihydroxyvitamin D3 in human promyelocytic leukemia HL-60 cells. Biomed Res
27(3):99–109
86. Suzuki T, Koyama Y, Ichikawa H, Tsushima K, Abe K, Hayakawa S, Kuruto-Niwa R,
Nozawa R, Isemura M (2005) 1,25-Dihydroxyvitamin D3 suppresses gene expression of
eukaryotic translation initiation factor 2 in human promyelocytic leukemia HL-60 cells. Cell
Struct Funct 30(1):1–6
87. Williams CJB (1849) Cod liver oil in phthisis. Lond J Med l:1–18